R6 Ballot (3rd Draft) FHIR CI-Build

Publish-box (todo) This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example ClinicalUseDefinition/example-interaction (XML)

Maturity Level : N/A
Responsible Owner: Biomedical Research and Regulation Work Group Standards Status : Informative Compartments : No defined compartments

Raw XML ( canonical form + also see XML Format Specification )

Interaction effect example (id = "example-interaction") 

<?xml version="1.0" encoding="UTF-8"?>

<ClinicalUseDefinition xmlns="http://hl7.org/fhir">
  <id value="example-interaction"/> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
    <valueCode value="brr"/> 
  </extension> 
  <!--   example product interacts with other drugs   -->
  <type value="interaction"/> 
  <subject> 
    

    <reference> 
      <reference value="MedicinalProductDefinition/example"/> 
    </reference> 
  </subject> 
  <interaction> 
    <interactant> 
      <itemCodeableConcept> 
        <coding> 
          <system value="http://ema.europa.eu/example/interactant"/> 
          <code value="alphaconazole"/> 
        </coding> 
      </itemCodeableConcept> 
    </interactant> 
    <interactant> 
      <itemCodeableConcept> 
        <coding> 
          <system value="http://ema.europa.eu/example/interactant"/> 
          <code value="betaconazole"/> 
        </coding> 
      </itemCodeableConcept> 
    </interactant> 
    <type> 
      <coding> 
        <system value="http://ema.europa.eu/example/interactionsType"/> 
        <code value="Inhibitor"/> 
      </coding> 
    </type> 
    <effect> 
      <concept> 
        <text value="Increased plasma concentration"/> 
      </concept> 
    </effect> 
    <management> 
      <text value="Careful monitoring of dose"/> 
    </management> 
  </interaction> 


</

ClinicalUseDefinition

>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.